Learning Center

Learning Center

Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Includes Multiple Live Events. The next is on 04/01/2023 at 1:00 PM (CDT)

    Course Date: April 1, 2023. This course focuses on increasing the knowledge and competence of clinicians and other healthcare professionals to help them successfully use DXA body composition analysis in the management of obesity, geriatric sarcopenia and other low muscle mass states, general health and pediatric skeletal disease. The inclusion of case studies will reinforce the knowledge gained and allow for application in the diagnosis, treatment and therapies of patients presenting with low bone mineral density.

    Course Date

    April 1, 2023

    Course Description

    This course focuses on increasing the knowledge and competence of clinicians and other healthcare professionals to help them successfully use DXA body composition analysis in the management of obesity, geriatric sarcopenia and other low muscle mass states, general health and pediatric skeletal disease. The inclusion of case studies will reinforce the knowledge gained and allow for application in the diagnosis, treatment and therapies of patients presenting with low bone mineral density.

    Target Audience

    The content is designed for healthcare providers responsible for reading and interpreting DXA scans, including specialists and generalists working in family medicine, general and internal medicine, rheumatology, endocrinology, obstetrics/gynecology, radiology, physical and occupational therapy, and research, as well as technologists.

    Learning Objectives

    After attending the course, participants should be better prepared to:

    1. Identify proper DXA technology for body composition analysis of fat, lean muscle and bone mass.
    2. List other methods of body composition analysis used in the clinical setting.
    3. Differentiate reference values and indices.
    4. Identify limitations of reference values and indices.
    5. Summarize scan acquisition for adult and pediatric patients.

    Method of Participation

    This activity will be offered in person, allowing the learners and faculty members to interact in a live, in-person, format on April 1, 2023. At the end of the activity, learners will be asked to evaluate the activity online and then claim credit and print certificates. Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit. 

    Rates

    image

    Cancellation Policy

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ACCME Accreditation Statement:

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this live educational activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    ASRT Credit Designation: 

    This activity has been approved by ASRT for 4.5 Category A continuing education credits.

    Date of Original Release and most recent Review or Update: This activity was most recently reviewed and released on July 25, 2022.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

    Schedule - April 1, 2023 - All times central (CHI/USA)
    image

    Hotel & Local Transportation

    image

    Renaissance Chicago North Shore Hotel

    933 Skokie Boulevard, Northbrook, Il 60062
    Phone: 1-847-498-6500

    ISCD has negotiated the following nightly rates for attendees. ISCD room rates are available March 28 to April 3. Click here to reserve your room at the discounted group rate. Discounted rates will be available until March 13, 2023. Single Traditional Guest Room: $119 plus tax - Traditional room options include one king or two queen beds. Visit Renaissance Chicago North Shore Hotel for more details on the hotel and amenities.  

    imageReserve your room at the ISCD discounted rate by March 13.

    imageAirport Information

    O'Hare International Airport

    Airport Phone +1 (800) 832-6352
    Website https://www.flychicago.com/oha...
    Hotel direction:  18 miles North

    image Transportation from Airport to Hotel

    There is no hotel shuttle available from the airport. Below are the recommended transportation options for getting from the airport to the hotel.

    image Hotel Parking

    Complimentary On-Site Parking Long Term Parking

    image Hotel Shuttle

    The hotel offers a complimentary shuttle anywhere within 5 miles of the hotel. The shuttle runs daily from 7am until 11pm. 

    image Transportation from Hotel to Downtown Chicago

    The hotel shuttle offers service to the Glencoe Station Metra stop which can be taken all the way south until the end of the line which is Ogilvie Transportation Center (OTC).

    Greg Yardley

    Sr. Medical Radiology Technologist and Researcher, NASA

    NASA Bone Mineral Laboratory

    Greg Yardley works as a SR. Medical Radiology Technologist and researcher in the NASA Bone Mineral Laboratory and NASA/JSC medical clinic for KBR in the government solutions division. His job requirements are performing and analyzing, Dual Energy x-ray absorptiometry (DXA) exams on both retired and active Astronauts. He also extracts, records, aids in bone density interpretation and distributes bone data from Dual Energy xray absorptiometry (DXA), Computed Tomography (CT), Magnetic resonance imaging devises. Greg also performs diagnostic medical x-rays for the NASA/JSC Flight medicine and occupational health clinic. 

    Greg began his healthcare career as an Emergency Medical Technician (EMT). He then furthered his medical education and received his certification as a registered radiology technologist. Upon completion of his Radiological Science courses. Greg has worked as a Radiology technologist in a Trauma level 1 Hospital, Level III hospital, urgent care, and multi-specialty clinic. At the time of his graduation Greg had also received extensive training not only in X-ray but also DXA, CT, and Ultrasound. In 2011 just previous to his current job Greg got a job as a Bone Density Technologist at a multi-specialty medical clinic where he performed and analyzed over 3000 DXA scans a year on every type of patient imaginable while also running the day-to-day operations of the Osteoporosis center.

    Disclosure: No Financial Relationships to disclose.

    Adam Kuchnia

    image

    Statement of independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    • Register
      • Early bird pricing available!
      • Non-Member - $300
      • Full Member - $200
      • MOC Only - $300
      • Community Member - $300
      • Professional Member - $300
      • Regular Price after 02/28/2023 11:59 PM
      • Non-Member - $400
      • Full Member - $300
      • MOC Only - $400
      • Community Member - $400
      • Professional Member - $400
    • More Information
  • Includes Multiple Live Events. The next is on 03/29/2023 at 2:00 PM (CDT)

    Course Date: March 29, 2023. This advanced densitometry course focuses on how vertebral fracture imaging advances the diagnosis and treatment of patients at risk of osteoporotic fractures. It emphasizes the importance of vertebral fractures in the clinical management of osteoporosis, including recognition of lateral spine images of a normal spine, vertebral fractures, and other findings that may be confused with vertebral fractures. Fracture recognition, analysis, and best-practice patient positioning are detailed to ensure ideal image acquisition, interpretation, and reporting.

    Course Date

    March 29, 2023

    Course Description

    This advanced densitometry course focuses on how vertebral fracture imaging advances the diagnosis and treatment of patients at risk of osteoporotic fractures. It emphasizes the importance of vertebral fractures in the clinical management of osteoporosis, including recognition of lateral spine images of a normal spine, vertebral fractures, and other findings that may be confused with vertebral fractures.  Fracture recognition, analysis, and best-practice patient positioning are detailed to ensure ideal image acquisition, interpretation, and reporting. It is recommended, but not required, that registrants attend the Osteoporosis Essentials/Quality Bone Densitometry Course (Clinician or Technologist) prior to attending the VFR course


    Target Audience

    The content is designed for healthcare providers responsible for reading and interpreting DXA scans, including specialists and generalists working in family medicine, general and internal medicine, rheumatology, endocrinology, obstetrics/gynecology, radiology, nuclear medicine, physical and occupational therapy, and research. The course is also appropriate for technologists.


    Learning Objectives

    After attending the course, participants should be better prepared to:

    1. Summarize best-practice methods utilized to recognize vertebral fractures on lateral spine images.
    2. Describe non-fracture abnormalities that may appear on a spine image.
    3. Identify characteristics of high-quality densitometric lateral spine images. 
    4. Identify the appropriate complementary technologies to complete vertebral fracture assessment. 
    5. Cite indications for VFA as stated in the 2015 ISCD Official Positions.

    Method of Participation

    This activity will be offered in person, allowing the learners and faculty members to interact in a live, in-person, format on March 29, 2023. At the end of the activity, learners will be asked to evaluate the activity online and then claim credit and print certificates. Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit. 


    Rates


    image

    Cancellation Policy

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ACCME Accreditation Statement:

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this live educational activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    ASRT Credit Designation: 

    This activity has been approved by ASRT for 4.5 Category A continuing education credits.

    Date of Original Release and most recent Review or Update: This activity was most recently reviewed and released on July 25, 2022.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

    Schedule - March 29, 2023 - All times central (CHI/USA)

    image

    Hotel & Local Transportation

    image

    Renaissance Chicago North Shore Hotel

    933 Skokie Boulevard, Northbrook, Il 60062
    Phone: 1-847-498-6500

    ISCD has negotiated the following nightly rates for attendees. ISCD room rates are available March 28 to April 3. Click here to reserve your room at the discounted group rate. Discounted rates will be available until March 13, 2023. Single Traditional Guest Room: $119 plus tax - Traditional room options include one king or two queen beds. Visit Renaissance Chicago North Shore Hotel for more details on the hotel and amenities.  

    imageReserve your room at the ISCD discounted rate by March 13.

    imageAirport Information

    O'Hare International Airport

    Airport Phone +1 (800) 832-6352
    Website https://www.flychicago.com/oha...
    Hotel direction:  18 miles North

    image Transportation from Airport to Hotel

    There is no hotel shuttle available from the airport. Below are the recommended transportation options for getting from the airport to the hotel.

    image Hotel Parking

    Complimentary On-Site Parking Long Term Parking

    image Hotel Shuttle

    The hotel offers a complimentary shuttle anywhere within 5 miles of the hotel. The shuttle runs daily from 7am until 11pm. 

    image Transportation from Hotel to Downtown Chicago

    The hotel shuttle offers service to the Glencoe Station Metra stop which can be taken all the way south until the end of the line which is Ogilvie Transportation Center (OTC).

    John Schousboe, MD, PhD, CCD

    Director, Park Nicollet Bone Densitometry Center; Consultant Rheumatologist, Park Nicollet Clinic; Research Investigator, HealthPartners Institute

    Dr. Schousboe is a rheumatologist and health services researcher who directs the bone densitometry center of Park Nicollet Clinic, a large integrated health care delivery system in Minneapolis, MN. He is an a Past President of the International Society for Clinical Densitometry (ISCD) and a Fellow of the American Society for Bone and Mineral Research (ASBMR). During a 16-year research career he has been an author on 200 peer-reviewed publications, the far majority of which have been in the field of diagnosis and management of osteoporosis. His contributions to science include development of a cost-effectiveness model that was used to conduct studies of the cost-effectiveness of bone densitometry in men and subgroups of older women and men defined by prevalent vertebral fracture, bone turnover marker levels, and bone density level; studies of the accuracy, prevalence, and clinical impact of vertebral fracture recognition on bone density lateral spine images; studies of medication adherence to osteoporosis therapies; studies of the identification and clinical significance of abdominal aortic calcification on lateral bone density spine images; and predictors of health care utilization and costs using Medicare Claims data.

    No Financial Relationships to Disclose (Last updated 02/09/2022)

    Dr. Sanford Baim, MD, FACR, CCD

    Professor of Medicine, Director of Bone Metabolic Disease, Division of Endocrinology and Metabolism

    RUSH University Medical Center

    Dr. Sanford Baim is Professor of Medicine, Director of Bone Metabolic Disease, Division of Endocrinology and Metabolism at RUSH University Medical Center. He is past president of the International Society for Clinical Densitometry, has published numerous articles, participated in the development of an interactive web-based teaching tool for bone densitometry and is presently engaged in osteoporosis clinical outcomes research. Additionally, he has served on the leadership boards of numerous conferences and steering committees tasked with setting official positions on the diagnoses and treatment of metabolic bone diseases, such as osteoporosis. Dr. Baim is currently developing a comprehensive, multidisciplinary, integrative strategic plan for the prevention of osteoporosis throughout the Rush University medical system.

    No Financial Relationships to Disclose (Last updated 06/01/2022)

    image

    Statement of independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    • Register
      • Early bird pricing available!
      • Non-Member - $300
      • Full Member - $200
      • MOC Only - $300
      • Community Member - $300
      • Professional Member - $300
      • Regular Price after 02/27/2023 11:59 PM
      • Non-Member - $400
      • Full Member - $300
      • MOC Only - $400
      • Community Member - $400
      • Professional Member - $400
    • More Information
  • Includes Multiple Live Events. The next is on 03/28/2023 at 11:00 AM (CDT)

    Course Date: March 28 & 29, 2023. The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.

    Course Date

    March 28 & 29, 2023.


    Course Description

    The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.


    Target Audience

    The course is most appropriate for those involved in the performance and interpretation of DXA scans and those managing patients with osteoporosis. It is open to MDs, PhDs, DOs, Nurse Practitioners, and Physician Assistants. Technologists may attend if they have previously taken the ISCD/IOF Osteoporosis Essentials for Technologists Course.


    Learning Objectives

    After attending the course, participants should be better prepared to:

    • Describe appropriate clinical evaluation of patients at risk for fragility fracture.
    • Summarize the value and importance of quality bone densitometry for the diagnosis of osteoporosis, assessment of fracture risk, and monitoring of BMD. 
    • Recognize errors in DXA analysis and reporting. 
    • Explain new and emerging guidelines that provide evidence-based information regarding skeletal health. 
    • Describe the use of current and new pharmacologic therapies for the management and treatment of osteoporosis, including adverse effects.

    Method of Participation

    This activity will be offered in person, allowing the learner to watch and ask questions in a live format on March 28 & 29, 2023. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

    Rates


    image

    Cancellation Policy

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ACCME Accreditation Statement:

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this live educational activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

     Schedule - Day 1 - All times Central Standard Time (CHI/USA)
    image


     Schedule - Day 2 -All times Central Standard Time (CHI/USA)

    image


    Hotel & Local Transportation

    image

    Renaissance Chicago North Shore Hotel

    933 Skokie Boulevard, Northbrook, Il 60062
    Phone: 1-847-498-6500

    ISCD has negotiated the following nightly rates for attendees. ISCD room rates are available March 28 to April 3. Click here to reserve your room at the discounted group rate. Discounted rates will be available until March 13, 2023. Single Traditional Guest Room: $119 plus tax - Traditional room options include one king or two queen beds. Visit Renaissance Chicago North Shore Hotel for more details on the hotel and amenities.  

    imageReserve your room at the ISCD discounted rate by March 13.

    imageAirport Information

    O'Hare International Airport

    Airport Phone +1 (800) 832-6352
    Website https://www.flychicago.com/oha...
    Hotel direction:  18 miles North

    image Transportation from Airport to Hotel

    There is no hotel shuttle available from the airport. Below are the recommended transportation options for getting from the airport to the hotel.

    image Hotel Parking

    Complimentary On-Site Parking Long Term Parking

    image Hotel Shuttle

    The hotel offers a complimentary shuttle anywhere within 5 miles of the hotel. The shuttle runs daily from 7am until 11pm. 

    image Transportation from Hotel to Downtown Chicago

    The hotel shuttle offers service to the Glencoe Station Metra stop which can be taken all the way south until the end of the line which is Ogilvie Transportation Center (OTC).

    Dr. Sanford Baim, MD, FACR, CCD

    Professor of Medicine, Director of Bone Metabolic Disease, Division of Endocrinology and Metabolism

    RUSH University Medical Center

    Dr. Sanford Baim is Professor of Medicine, Director of Bone Metabolic Disease, Division of Endocrinology and Metabolism at RUSH University Medical Center. He is past president of the International Society for Clinical Densitometry, has published numerous articles, participated in the development of an interactive web-based teaching tool for bone densitometry and is presently engaged in osteoporosis clinical outcomes research. Additionally, he has served on the leadership boards of numerous conferences and steering committees tasked with setting official positions on the diagnoses and treatment of metabolic bone diseases, such as osteoporosis. Dr. Baim is currently developing a comprehensive, multidisciplinary, integrative strategic plan for the prevention of osteoporosis throughout the Rush University medical system.

    No Financial Relationships to Disclose (Last updated 06/01/2022)

    Dr. Ronald C. Hamdy, MD

    Coming Soon

    image

    Statement of independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    • Register
      • Early bird pricing available!
      • Non-Member - $925
      • Full Member - $625
      • MOC Only - $925
      • Community Member - $925
      • Professional Member - $925
      • Regular Price after 03/01/2023 12:00 AM
      • Non-Member - $1,025
      • Full Member - $725
      • MOC Only - $1,025
      • Community Member - $1,025
      • Professional Member - $1,025
    • More Information
  • Includes Multiple Live Events. The next is on 03/28/2023 at 11:00 AM (CDT)

    Course Date: March 28 & 29, 2023. The core elements of this program focus on performing quality DXA scans, dissecting the data and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive and informative. The course emphasizes technical excellence in the performance, analysis and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.

    Course Date

    March 28 & 29, 2023.


    Course Description

    The core elements of this program focus on performing quality DXA scans, dissecting the data and applying this knowledge to a technologist’s role in patient care. This course, which focuses on quality DXA, is innovative, interactive and informative.  The course emphasizes technical excellence in the performance, analysis and troubleshooting of bone densitometry scans. It provides standard practices and applications to raise the quality of DXA scan procedures and their impact on patient care. The program is designed to enhance awareness of the technical expertise involved in performing bone densitometry and applying protocols to address the everyday challenges. Attendees with come away with a strong sense of the considerable impact that a technologist plays in the delivery of quality DXA, and how that influences patient management.


    Target Audience

    The course is most appropriate for those involved in the performance of DXA scans and open to any health professional performing these scans.


    Learning Objectives

    After attending the course, participants should be better prepared to:

    1. Design and implement quality control and assurance practices
    2. Perform a precision assessment and appreciate the requirement for clinical care  
    3. Identify the anatomy relevant to clinical DXA scanning 
    4. Implement consistent and appropriate technical acquisition and analysis techniques  
    5. Perform a fracture risk assessment using FRAX 
    6. Provide DXA interpreters sufficient information for a high-quality DXA report 
    7. Understand how specific medical conditions and medications affect bone density 
    8. Demonstrate how to access features within the DXA software 
    9. Critically evaluate DXA scans to identify acquisition and analysis errors and implement resolution methods 
    10. Recognize how technical errors impact clinical interpretation and patient care

    Method of Participation

    This activity will be offered in person, allowing the learner to watch and ask questions in a live format on March 28 & 29, 2023. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

    Registration Fee



    image

    Cancellation Policy

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ASRT Credit Designation: 

    This activity has been approved by ASRT for 11.5 Category A continuing education credits.

    Date of Original Release and most recent Review or Update: This activity was most recently reviewed and released on May 1, 2022.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

    Schedule - Day 1 - Tuesday, March 28, 2022 - All times central (CHI/USA)

    image

     Schedule - Day 2 - Wednesday, March 29, 2023 - All times central (CHI/USA)

    image

    Hotel & Local Transportation

    image

    Renaissance Chicago North Shore Hotel

    933 Skokie Boulevard, Northbrook, Il 60062
    Phone: 1-847-498-6500

    ISCD has negotiated the following nightly rates for attendees. ISCD room rates are available March 28 to April 3. Click here to reserve your room at the discounted group rate. Discounted rates will be available until March 13, 2023. Single Traditional Guest Room: $119 plus tax - Traditional room options include one king or two queen beds. Visit Renaissance Chicago North Shore Hotel for more details on the hotel and amenities.  

    imageReserve your room at the ISCD discounted rate by March 13.

    imageAirport Information

    O'Hare International Airport

    Airport Phone +1 (800) 832-6352
    Website https://www.flychicago.com/oha...
    Hotel direction:  18 miles North

    image Transportation from Airport to Hotel

    There is no hotel shuttle available from the airport. Below are the recommended transportation options for getting from the airport to the hotel.

    image Hotel Parking

    Complimentary On-Site Parking Long Term Parking

    image Hotel Shuttle

    The hotel offers a complimentary shuttle anywhere within 5 miles of the hotel. The shuttle runs daily from 7am until 11pm. 

    image Transportation from Hotel to Downtown Chicago

    The hotel shuttle offers service to the Glencoe Station Metra stop which can be taken all the way south until the end of the line which is Ogilvie Transportation Center (OTC).

    Maureen A. Costello

    AAS, RT(R), CBDT

    Maureen has been a Radiologic Technologist for the past 25 years. As a diagnostic Rad. Tech., she specialized in Trauma and Surgical radiography at one of two Trauma Centers in the greater Chicago land area, and then moved into Orthopedic Radiography before moving onto DXA in 2003. She is the Lead Tech. At the University of Chicago Hospitals, Dept. of Endocrinology. While the bulk of her day consists of performing BMD’s, she is also responsible for QA/QC of equipment and reports, monitoring and performing multiple studies and on-site training of not only office staff but also tutorials for 4th year Med. Students. Maureen has been certified since 2003 and has been an instructor with the ISCD since 2007.


    Disclosure: No Financial Relationships to Disclose

    Diane Krueger, BS, CBDT

    Program Manager Osteoporosis Clinical Research Program

    UW Osteoporosis Clinic

    Diane Krueger received her Bachelor of Science degree at the University of Wisconsin-Madison. She is an ISCD-certified clinical densitometrist and a certified clinical research coordinator through the Association of Clinical Research Professionals. She has been program manager of the University of Wisconsin Osteoporosis Clinical Research Program since its inception in 1993. Ms. Krueger has extensive clinical research experience in osteoporosis and bone densitometry, having coordinated multiple industry and investigator-initiated studies. In collaboration with the UW Osteoporosis Program, she has published over 90 manuscripts and authored or presented over 200 abstracts. Her service with ISCD has included serving as Technologist Bone Densitometry Course faculty since 2006 and chairing the related Update Annual Meeting Committees. In her leadership capacity, she is currently Education Council chair and serves on the Executive Committee and Board. Additionally, she previously held several officer positions including Secretary and four Presidential seats.

    Disclosures: Consulting Fee: Amgen; Contracted Research: Radius 

    Course Planning Committee

    Coming Soon

    Course Content Reviewers

    Coming Soon

    March 2023 Course Faculty

    Coming Soon

    image

    Statement of independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    • Register
      • Early bird pricing available!
      • Non-Member - $525
      • Full Member - $425
      • MOC Only - $525
      • Community Member - $525
      • Professional Member - $525
      • Regular Price after 02/28/2023 11:59 PM
      • Non-Member - $625
      • Full Member - $525
      • MOC Only - $625
      • Community Member - $625
      • Professional Member - $625
    • More Information
  • Includes Multiple Live Events. The next is on 03/28/2023 at 8:00 AM (CDT)

    Course Date: March 28, 2023. This ISCD Orthopedic Osteoporosis and Densitometry Course is a live activity consisting of a variety of sessions in didactic lectures, question and answer sessions and case-based interactive presentations. Overall, this variety of learning formats will allow learners to receive information from leading experts in important topic areas. Further, the structure and format of the course will provide learners with opportunities to engage with and learn from their colleagues. The case presentations are designed to provide learners with tangible examples that they might face in their own professional practice. Further, panel discussions provide a forum for discussing key components of orthopedic densitometry.

    Course Date

    March 28, 2023

    Course Description

    This ISCD Orthopedic Osteoporosis and Densitometry Course is a live activity consisting of a variety of sessions in didactic lectures, question and answer sessions and case-based interactive presentations. Overall, this variety of learning formats will allow learners to receive information from leading experts in important topic areas. Further, the structure and format of the course will provide learners with opportunities to engage with and learn from their colleagues. The case presentations are designed to provide learners with tangible examples that they might face in their own professional practice.  Further, panel discussions provide a forum for discussing key components of orthopedic densitometry.

    This activity is supported by an educational donation provided by Amgen.


    Target Audience

    The ISCD Orthopedic Osteoporosis and Densitometry Course is designed for healthcare professionals with an interest in orthopedics, osteoporosis, and bone health specifically over the age of 50, including those working in orthopedics, radiology and diagnostic imaging, physical and occupational therapy, public health, and research. These include orthopedic surgeons, physicians, nurses, nurse practitioners, physician assistants, radiology technologists, physical therapists, and occupational therapists. 

    Osteoporosis, both primary and secondary, is a common problem leading to fragility fractures and poor outcomes of elective orthopedic surgery. Although orthopedic surgeons care for the majority of patients having fractures, there is a need to support training in current methods of bone health assessment, including bone densitometry. The under-diagnosis and treatment of osteoporosis continues to occur even though effective therapy exists to improve bone health and to reduce fracture risk. This gap in osteoporosis diagnosis and treatment contributes to the epidemic of new fractures and complications related to poor bone health in elective orthopedic surgery. Those caring for orthopedic patients must be familiar with and aware of current guidelines regarding osteoporosis diagnosis, fracture risk assessment, and a basic understanding of therapeutic agents.

    In addition to fracture prevention and post fracture care, elective orthopedic surgery patients over age of 50 years have a significant risk of having poor bone health including osteoporosis.  Poor bone health has been associated with many adverse events of elective orthopedic surgery including periprosthetic fracture, implant subsidence, non-union and delayed union, hardware loosening, revision surgery, and overall poorer patient reported outcomes. In spine surgery, similar adverse events can occur including proximal junction failure at the end of fusions, proximal fracture with neurologic injury, and revision surgery. Unfortunately, less than 5% of orthopedic surgeons order testing for bone health prior to elective surgery.

    To close the diagnosis gap, this course will review osteoporosis diagnosis guidelines, diagnostic testing basics including the application and interpretation of bone densitometry, and newer methods to assess bone health of fracture and elective surgery patients. Further, the course addresses how to initiate treatment based on clinical assessment and published guidelines. The dissemination of evidence-based information on risk/benefit balance could help reduce the treatment gap and improve patient health. Orthopedic surgeons and other members of the healthcare team may be unfamiliar with how elevated fracture risk and prevalent fragility fracture warrants pharmacological intervention of osteoporosis.

    Lastly, osteoporosis is widely recognized as an important public health problem because of the related morbidity, mortality and high cost associated with fracture. Bone mineral density (BMD) measurement by dual-energy x-ray absorptiometry (DXA) is an internationally accepted standard-of-care screening and osteoporosis diagnostic tool. This course provides essential information regarding BMD acquisition, interpretation and monitoring.



    Learning Objectives

    After attending the course, participants should be better prepared to:

    1. Describe the principles of DXA including indications, interpretation, monitoring and potential pitfalls.
    2. Utilize advanced densitometry techniques such as trabecular bone score, vertebral fracture assessment, and opportunistic CT in clinical practice.
    3. Ensure all fragility fracture patients receive secondary fracture care
    4. Screen elective surgery patients over age 50 years for poor bone health and provide access to osteoporosis care if warranted
    5. Understand various pharmacological treatments available and treatment algorithms.
    6. Understanding the importance of sarcopenia, frailty, fall risk assessment and fall prevention.

    The ISCD Orthopedic Osteoporosis and Densitometry Course provides the most current, clinically relevant, and evidence-based information on bone health assessment and orthopedic surgery. This educational program is designed to improve learner competence by providing targeted opportunities for presenting the latest information in the research, prevention, diagnosis, treatment, and advances in bone health assessment and management in both fracture and elective orthopedic surgery patients. Learners will have the opportunity to take the knowledge gained from this educational opportunity and properly and consistently apply it into their professional practices. The ISCD Orthopedic Osteoporosis and Densitometry Course Committee developed this comprehensive course to include the following topics:


    Method of Participation

    This activity will be offered in person, allowing the learners and faculty members to interact in a live, in-person, format on March 28, 2023. At the end of the activity, learners will be asked to evaluate the activity online and then claim credit and print certificates. Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit. 


    Rates


    image

    Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    ACCME Accreditation Statement:

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this live educational activity for a maximum of 9 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    Date of Original Release and most recent Review or Update: This activity is currently under review.

    Deadline to Claim Credit:

    Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.

    Schedule - March 28, 2023 - All times central (CHI/USA)

    image

    Hotel & Local Transportation

    image

    Renaissance Chicago North Shore Hotel

    933 Skokie Boulevard, Northbrook, Il 60062
    Phone: 1-847-498-6500

    ISCD has negotiated the following nightly rates for attendees. ISCD room rates are available March 28 to April 3. Click here to reserve your room at the discounted group rate. Discounted rates will be available until March 13, 2023. Single Traditional Guest Room: $119 plus tax - Traditional room options include one king or two queen beds. Visit Renaissance Chicago North Shore Hotel for more details on the hotel and amenities.  

    imageReserve your room at the ISCD discounted rate by March 13.

    imageAirport Information

    O'Hare International Airport

    Airport Phone +1 (800) 832-6352
    Website https://www.flychicago.com/ohare/home/
    Hotel direction:  18 miles North

    image Transportation from Airport to Hotel

    There is no hotel shuttle available from the airport. Below are the recommended transportation options for getting from the airport to the hotel.

    image Hotel Parking

    Complimentary On-Site Parking Long Term Parking

    image Hotel Shuttle

    The hotel offers a complimentary shuttle anywhere within 5 miles of the hotel. The shuttle runs daily from 7am until 11pm. 

    image Transportation from Hotel to Downtown Chicago

    The hotel shuttle offers service to the Glencoe Station Metra stop which can be taken all the way south until the end of the line which is Ogilvie Transportation Center (OTC).

    Paul A. Anderson, MD

    Professor of Orthopedic Surgery

    University of Wisconsin

    Paul A. Anderson, MD, is an orthopedic spine surgeon with special interest in orthopedic implants, spine trauma, tumors, cervical spine, and geriatric spinal diseases. His undergraduate and Masters degrees are from The University of Michigan in Chemical Engineering. He completed medical school and residency at Wayne State University and a spine fellowship under Dr. Henry Bohlman. He is currently Professor of Orthopedic Surgery and Professor in Biomedical Engineering at the University of Wisconsin. He has been President of the Cervical Spine Research Society, President of the Lumbar Spine Research Society and has held various positions in a number of spinal and orthopedic societies. Dr. Anderson has served as a member as well as Chairman of the AAOS Biomedical Engineering Committee, Co-Chair of ASTM F04.25, Clinical Chair of ASTM F04, FDA Orthopedic Device Forum, and has testified at FDA panels.He currently serves as Chairman of the Own the Bone Committee of the American Orthopaedic Association (AOA) as well as a member of their Executive Committee.

    Disclosures: 

    Amgen (Self) : Consultant (Status: Ongoing); Medtronic (Self) : Consultant (Status: Ongoing); Radius Medical (Self) : Consultant (Status: Ongoing); Regeneration technology (Self) : Other Financial or Material Support (Status: Ongoing), Royalties (Status: Ongoing)

    Dato' Dr. Joon-Kiong Lee, DSPN, DJN MBBS, FRCS, MS ORTHO, AM, CCD

    Deputy Medical Director and Consultant Orthopedic Surgeon

    Beacon Hospital

    Dato' Dr. Lee is currently Deputy Medical Director, Chair of the Surgical Committee at Beacon Hospital, Petaling Jaya, Selangor, Malaysia. He is President of the Asia Pacific Osteoporosis and Fragility Fracture Society (APOFFS), a section of Asia Pacific Orthopaedic Association (APOA). 

    Dato' Dr. Lee is also President of the Fragility Fracture Network Malaysia (FFNM) and the Lead for FFNM Fracture Liaison Service (FLS) Framework. He is President of the Malaysian Bone Health Optimization Network (MyBONe) and Past President of International Society for Clinical Densitometry (ISCD) with 2018 ISCD Dr. Paul D. Miller Service Award. 

    Dato' Dr. Lee serves as the Lead of the ISCD Orthopedic Osteoporosis and Densitometry Course, Chair of the Asia Pacific Regional Advisory Council (RAC) of the International Osteoporosis Foundation (IOF) with the 2020 IOF President’s Award.  He is Co-Chair of the Asia Pacific Fragility Fracture Alliance (APFFA) and Co-Editor of the APFFA Hip Fracture Registry Toolkit. 

    Additionally, he is a Board member for Fragility Fracture Network (FFN), Founding and Past President of the Osteoporosis Awareness Society of Kuala Lumpur and Selangor (OASKLS) and also the Past President of Malaysian Osteoporosis Society (MOS). He is a member of the steering committee for the Asia Pacific Bone Academy (APBA) and South East Asia, India and Hong Kong (SEAIHK) Bone Academy.

    Disclosures: No relationships to disclose.

    Neil Binkley, MD, CCD

    Professor of Medicine

    University of Wisconsin-Madison

    Dr. Neil Binkley earned his medical degree from the University of Wisconsin and subsequently trained in Internal Medicine at the Marshfield Clinic. After several years in private practice, he returned to the University of Wisconsin and completed a Geriatrics fellowship. He is a Professor in the Divisions of Geriatrics and Endocrinology at the University of Wisconsin School of Medicine and Public Health. He is also Director of the UW Osteoporosis Clinical Research Program and Associate Director of the UW Institute on Aging. He is past President of the International Society for Clinical Densitometry, Associate Editor of Osteoporosis International and a member of the International Osteoporosis Foundation Committee of Scientific Advisors. His current research involves improvement in 25(OH)D measurement, evaluation of approaches to optimize assessment of vitamin D status, evaluation of functional assessment in older adults and the importance of sarcopenia in fracture risk. Dr. Binkley has published over 300 papers, served on expert committees and panels for AACE, ASBMR, IOF and ISCD.

    Disclosures: Amgen: Consultant; Radius: Research Support

    Coming Soon

    image

    Statement of independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

    • Register
      • Early bird pricing available!
      • Non-Member - $725
      • Full Member - $425
      • MOC Only - $725
      • Community Member - $725
      • Professional Member - $725
      • Regular Price after 02/27/2023 11:59 PM
      • Non-Member - $825
      • Full Member - $525
      • MOC Only - $825
      • Community Member - $825
      • Professional Member - $825
    • More Information
  • Treatments for Osteoporosis: Combination or Sequence? Does Order Matter?

    Activity approved for 1.5 ASRT Category A Credits
    Activity approved for up to 1.0 AMA PRA Category 1 Credits™
    Activity Expires December 31, 2023

    Activity Description

    Treatments for Osteoporosis: Combination or Sequence? Does Order Matter?

    Learning Objectives

    1. The attendee should understand that anabolic treatment is most effective when given ab initio, before antiresorptive treatment
    2. The attendee should understand that anabolic treatments must be followed by antiresorptives to avoid losing all the gain
    3. The attendee should understand that with certain specific exceptions, antiresorptives should not be given concurrently with anabolics.

    Instructions

    Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

    Registration Fees

    image

    Cancellation Policy

    On-Demand/ Enduring Material Cancellation Purchases of on-demand or enduring educational materials are non-refundable. 

    On-Demand/Enduring Material Program Changes or Cancellations  ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

    ACCME Accreditation Statement

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this enduring educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    ASRT Credit Designation 

    This activity has been approved by ASRT for 1.50 Category A continuing education credits.

    Date of Original Release and most recent Review or Update 

    This activity was most recently reviewed and released on December 21, 2022, and will expire on December 31, 2023

    Nelson B. Watts, MD, FACP, MACE, CCD

    Director, Osteoporosis and Bone Health Services

    Mercy Health, Cincinnati OH

    Nelson B. Watts, MD, FACP, MACE, CCD, currently serves as Director of Osteoporosis and Bone Health Services for Mercy Health, an integrated health system in Cincinnati, Ohio. He has a long career in osteoporosis research at Emory University and the University of Cincinnati. He has served as President of the American College of Endocrinology, President of the International Society of Clinical Densitometry, Chair of the FDA’s Advisory Committee for Endocrine and Metabolic Drugs and on the ABIM subspecialty board in Endocrinology and Metabolism. He is active in numerous professional organizations and serves on several editorial boards. He has published numerous, books, book chapters, abstracts and articles in such journals as the New England Journal of Medicine and the Journal of the American Medical Association.

    Disclosures: 

    Amgen and Radius (Self) : Speaker's Bureau / Teaching Engagements (Status: Ongoing)

    Jennifer Kelly, DO, FACE, CCD

    Director of the Metabolic Bone Program

    University Of Vermont

    Disclosures: No relationships to disclose.

    Course Planners and Managers

    Harold Rosen, MD, CCD No Financial Relationships to Disclose
    Wendy Tolman-Andrews, CBDT No Financial Relationships to Disclose
    Peter Brown, MS No Financial Relationships to Disclose
    Jesse Palmer No Financial Relationships to Disclose

    Course Content Reviewers

    William Leslie, MD, FRCPC, MSc, CCD No Financial Relationships to Disclose

    Course Faculty, Moderators, and Content Authors

    Nelson B. Watts, MD, FACP, MACE, CCD : Amgen and Radius (Self) : Speaker's Bureau / Teaching Engagements (Status: Ongoing)
    Jennifer Kelly, DO, FACE, CCD : No Financial Relationships to Disclose

    image

    Statement of Independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use 

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendee Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program. 

  • FRAX has been available since 2008 and is widely used worldwide. This lecture will provide a background to FRAX, its potential and limitations, and ongoing efforts to update the FRAX tool. These updates range from taking account of less-validated risk factors (adjustments) to a full redevelopment of the FRAX risk factor calculation engine.

    Activity approved for 1.25 ASRT Category A Credits
    Activity approved for up to 1.25 AMA PRA Category 1 Credits™
    Activity Expires September 1, 2023

    Activity Description

    FRAX has been available since 2008 and is widely used worldwide. This lecture will provide a background to FRAX, its potential and limitations, and ongoing efforts to update the FRAX tool. These updates range from taking account of less-validated risk factors (adjustments) to a full redevelopment of the FRAX risk factor calculation engine.

    Learning Objectives

    1. The attendee should understand the factors that go into the FRAX calculation 
    2. The attendee should understand the limitations of the current FRAX calculator 
    3. The attendee should understand the value of the enhancements that have already been done to FRAX, and those proposed. 
    4. Identify basis of fracture probability compared to fracture risk 
    5. Explain the minimum requirements for inclusion of risk factors within FRAX 
    6. Describe the potential use of adjustments to FRAX probabilities 

    Instructions

    Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

    Registration Fees

    image

    Cancellation Policy

    On-Demand/ Enduring Material Cancellation
    Purchase of on-demand or enduring educational materials are non-refundable.

    On-Demand/Enduring Material Program Changes or Cancellations 
    ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

    ACCME Accreditation Statement 

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this enduring educational activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    ASRT Credit Designation 

    This activity has been approved by ASRT for 1.25 Category A continuing education credits.

    Date of Original Release and most recent Review or Update 

    This activity was most recently reviewed and released on August 11, 2022, and will expire on September 1, 2023

    Eugene McCloskey, MD

    University of Sheffield Metabolic Bone Centre

    Eugene McCloskey is Professor in Adult Bone Diseases in the Academic Unit of Bone Metabolism and Mellanby Centre for Musculoskeletal Research at the University of Sheffield; and Director of the MRC Versus Arthritis Centre for Integrated Research in Musculoskeletal Ageing (www.CIMAuk.org). He has published over 430 peer-reviewed publications, book chapters and reviews and is an acknowledged authority in the fields of vertebral fracture definition, osteoporosis epidemiology and treatment, fracture risk assessment and bone health in cancer. He contributed to the development of the FRAX tool and the subsequent guideline from the National Osteoporosis Guideline Group. Professor McCloskey is on a number of editorial boards and is a member of committees within organisations including the boards of IOF and ESCEO. He is also the past President of the Bone Research Society. In 2016, he was awarded the IOF Medal of Achievement, presented annually to recognise an individual researcher who has significantly advanced the field of osteoporosis through original and outstanding scientific contributions. In 2018, he was honoured with the ECTS Philippe Bordier Award for a significant clinical contribution to the field of bone and calcified tissue.

    Disclosures: 

    Consulting Fee (Amgen, Fresenius Kabi, ObsEva, UCB); Fees for Non-CME Services (Speaker Honoraria from Amgen, UCB); Contracted Research (Amgen, Consilient Health, ObsEva, UCB)

    Kaitlyn Barrett, DO (Moderator)

    Endocrinologist

    The University of Vermont Medical Center

    Kaitlyn Barrett, DO, is an Endocrinologist and Assistant Professor at the University of Vermont Medical Center and Larner College of Medicine where she also serves as the Associate Program Director of the Endocrine Fellowship Program. She completed her endocrine fellowship and internal medicine residency training at UVMMC, and recieved her medical degree from New York Institute of Technology College of Osteopathic Medicine in 2014. Clinical interests include osteoporosis and calcium disorders, diabetes and cardiometabolic disease.

    Disclosures: No relationships to disclose.

    Course Planners and Managers

    Harold Rosen, MD, CCD No Financial Relationships to Disclose
    Wendy Tolman-Andrews, CBDT No Financial Relationships to Disclose
    Peter Brown, MS No Financial Relationships to Disclose
    Jesse Palmer No Financial Relationships to Disclose

    Course Content Reviewers

    S. Kumar, MD, CCD No Financial Relationships to Disclose

    Course Faculty, Moderators, and Content Authors

    Eugene McClosky, MD - Consulting Fee (Amgen, Fresenius Kabi, ObsEva, UCB); Fees for Non-CME Services (Speaker Honoraria from Amgen, UCB); Contracted Research (Amgen, Consilient Health, ObsEva, UCB)
    Kaitlyn Barrett, DO, Moderator - No Financial Relationships to Disclose

    image

    Statement of Independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use 

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record learner’s personal information as provided on evaluations to allow for issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendee Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program. 

  • Trabecular Bone Score (TBS) has recently become an additional analysis that can be undertaken using the DXA scans. The purpose of this lecture is to provide an overview of TBS, along with guidance in the short term, before there is an official ISCD position statement developed at the next annual meeting (2023).

    Activity approved for 1.0 ASRT Category A Credits 
    Activity approved for up to 1.0 AMA PRA Category 1 Credits™ 
    Activity Expires December 1, 2023

    Trabecular Bone Score (TBS) has recently become an additional analysis that can be undertaken using the DXA scans. The purpose of this lecture is to provide an overview of TBS, along with guidance in the short term, before there is an official ISCD position statement developed at the next annual meeting (2023). 

    Learning Objectives:

    1. A high-level overview of TBS and data supporting its use
    2. When and how TBS should be performed
    3. How TBS might be reported, and finally
    4. Consider the clinical use of TBS

    Instructions: Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

    image

    ACCME Accreditation Statement: The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™ The International Society for Clinical Densitometry designates this enduring educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    ASRT Credit Designation: This activity is approved by ASRT for 1.0 Category A continuing education credits.

    Date of Original Release and most recent Review or Update: This activity was most recently reviewed and released on November 1, 2022, and will expire on December 1, 2023.

    Deadline to Claim Credit: Participants must complete the activity, the activity survey, and claim credits before the activity expiration date.

    Neil Binkley, MD, CCD

    Professor of Medicine

    University of Wisconsin-Madison

    Dr. Neil Binkley earned his medical degree from the University of Wisconsin and subsequently trained in Internal Medicine at the Marshfield Clinic. After several years in private practice, he returned to the University of Wisconsin and completed a Geriatrics fellowship. He is a Professor in the Divisions of Geriatrics and Endocrinology at the University of Wisconsin School of Medicine and Public Health. He is also Director of the UW Osteoporosis Clinical Research Program and Associate Director of the UW Institute on Aging. He is past President of the International Society for Clinical Densitometry, Associate Editor of Osteoporosis International and a member of the International Osteoporosis Foundation Committee of Scientific Advisors. His current research involves improvement in 25(OH)D measurement, evaluation of approaches to optimize assessment of vitamin D status, evaluation of functional assessment in older adults and the importance of sarcopenia in fracture risk. Dr. Binkley has published over 300 papers, served on expert committees and panels for AACE, ASBMR, IOF and ISCD.

    Disclosures: Amgen: Consultant; Radius: Research Support

    William Leslie, MD, MSc, CCD

    Professor of Medicine and Radiology

    University of Manitoba

    Dr. Leslie is Professor of Medicine and Radiology at the University of Manitoba with over 450 peer-reviewed publications. His research interests are in fracture risk assessment, osteoporosis testing and other nuclear diagnostic techniques. He is Past President of the International Society for Clinical Densitometry, Past Chair of the Osteoporosis Canada Scientific Advisory Council, co-led the “2010 Clinical Practice Guidelines in Osteoporosis”, Director of the Manitoba Bone Density Program, and Co-Director of the Winnipeg PET Imaging Centre.

    Disclosures: No relationships to disclose.

    Course Planners and Managers

    Campbell Macgregor - No Financial Relationships to Disclose

    Course Content Reviewers

    S. Kumar, MD, CCD -  No Financial Relationships to Disclose

    Course Faculty and Content Authors

    Dr Neil Binkley, MD - Amgen: Consultant; Radius: Research Support

    Dr William Leslie, MD - No Financial Relationships to Disclose

    Statement of independence
    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in course material. No Commercial Support has been provided for this activity

    Disclaimer 
    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use 
    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement
    The ISCD will record learner’s personal information as provided on evaluations to allow for issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendance Cancellation Policy
    All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

    Course Changes or Cancellations
    ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.


  • The purpose of this session will be to provide an overview of the methods used to develop the PVA Bone Health CPG and the appropriate drug therapy for the prevention and treatment of osteoporosis in persons with SCI.

    Activity approved for 1.5 ASRT Category A Credits
    Activity approved for up to 1.5 AMA PRA Category 1 Credits™
    Activity Expires February 1, 2024

    Activity Description

    The purpose of this session will be to provide an overview of the methods used to develop the PVA Bone Health CPG and the appropriate drug therapy for the prevention and treatment of osteoporosis in persons with SCI.

    Learning Objectives

    1. The attendee should understand the amount of vitamin D recommended after spinal cord injury.
    2. The attendee should understand the amount and route of administration recommended for calcium after spinal cord injury, and how it is modified in patients with kidney stones.
    3. The attendee should understand the agents available for the prevention of bone loss after spinal cord injury and should prioritize administration of those with a proven track record both for efficacy and safety in patients with spinal cord injury.

    Instructions

    Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

    Registration Fees

    image

    Cancellation Policy

    On-Demand/ Enduring Material Cancellation
    Purchases of on-demand or enduring educational materials are non-refundable.

    On-Demand/Enduring Material Program Changes or Cancellations 
    ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

    ACCME Accreditation Statement

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this enduring educational activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    ASRT Credit Designation 

    This activity has been approved by ASRT for 1.50 Category A continuing education credits.

    Date of Original Release and most recent Review or Update 

    This activity was most recently reviewed and released on January 13, 2023, and will expire on February 1, 2024

    Dr. Christopher Cirnigliaro, PhD

    Investigator

    James J. Peters VA Medical Center

    Dr. Christopher M. Cirnigliaro, is the research laboratory manager and Investigator for the Veterans Affairs Rehabilitation, Research, and Development National Center for the Medical Consequences of Spinal Cord Injury located at the James J. Peters VA Medical Center. He is a clinical exercise physiologist and certified bone densitometry technician, with expertise in DXA analysis. His research investigates the prevention and reversal of bone and muscle loss after SCI, including clinical trials of bisphosphonates and denosumab, and extensive cross-sectional documentation of body composition changes following SCI. Dr. Cirnigliaro was also a member of the ISCD task force to develop the bone density testing guidelines in persons with SCI and is currently a member of the committee assigned to write the Clinical Practice Guideline entitled “Bone Health and Osteoporosis Management in Individuals with Spinal Cord Injury” that is sponsored by the Paralyzed Veterans of America.

    Disclosures: No relationships to disclose.

    Anthony Scott. Burns, MD MSc

    Professor of Medicine, University of Toronto

    UHN - Toronto Rehabilitation Institute, Lyndhurst Centre

    Anthony S. Burns graduated from the Yale University School of Medicine in 1994, and afterwards completed combined residency training in Internal Medicine and Physical Medicine & Rehabilitation at the Sinai Hospital of Baltimore - Johns Hopkins University program, followed by a SCI fellowship at the University of Alabama at Birmingham. He is a past participant in the Rehabilitation Medicine Scientist Training Program, sponsored by the Association of Academic Physiatrists (AAP) and funded by the U.S. National Institutes of Health. From 2000 through 2007, he was Assistant Professor, Department of Rehabilitation Medicine, Thomas Jefferson University, Philadelphia PA; Assistant Director of the Regional SCI Center of the Delaware Valley; and adjunct Assistant Professor, Department of Neurobiology and Anatomy, Drexel University College of Medicine, Philadelphia PA. In 2007, Dr. Burns joined the University Health Network - Toronto Rehabilitation Institute Spinal Cord Rehabilitation Program, the largest program of its kind in Canada, and was the Medical Director from 2007 – 2012. Currently he is a Professor in the Division of Physiatry, Department of Medicine, University of Toronto, and Affiliate Scientist, Neural Engineering and Therapeutics (NET) Team of the KITE (Knowledge Innovation Talent Everywhere) Research Institute. His clinical and research interests focus on the determination and measurement of outcomes following SCI, as well as the clinical management of spinal cord injuries and related secondary complications.

    Disclosures: No relationships to disclose.

    Beverley Catharine Craven, MD, MSc, FRCPC, FASIA, FCAHS

    Senior Scientist, Professor

    UHN - Toronto Rehabilitation Institute, Lyndhurst Centre

    Beverley. Catharine ( Cathy) Craven, BA, MD, FRCPC. MSc, FASIA, FCAHS Cathy Craven is the Toronto Rehabilitation Institute/ University of Toronto Chair in Spinal Cord Injury (SCI) Rehabilitation, Professor in the Department of Medicine at the University of Toronto, Medical Director of the Spinal Cord Rehabilitation Program and a Senior Scientist at KITE Research Institute within University Health Network. Dr Craven is a Fellow of the Canadian Academy of Health Sciences and a Fellow of the American Spinal Injury Association She has clinical and research expertise in health services and medical rehabilitation after Spinal Cord Injury. Dr. Craven is Chair of the Canadian SCI - Rehabilitation Association (www.cscira.org), Panel Chair for the 2021 PVA Consortium’s Bone Health and Osteoporosis Management Clinical Practice Guideline and participated in develpment of the ISCD 2019 Position Statement Regarding Bone Density Testing After Spinal Cord Injury. She leads the Canadain National SCI Implementation and Evaluation Quality Care Consortium (www.sciconsortium.ca) and is Co-Primary Investigator for the Can-SCIP guidelines (https://kite-uhn.com/can-scip)... Craven has deveoped and implemented a tool for measruing distal fmeur and proximal tibia BMD for individuals with SCI using a poly carbonate positioning device and the Hologic lumbar spine software https://www.kite-uhn.com/clinical/tools/knee-dxa-protocol. She has published over 200 articles on related topics and obtained 21.M dollars in research funding as a primary investigator (ORCID 0000-0001-8234-6803). www.cravenlab.ca; #@drcathycraven

    Disclosures: 

    Canadian Spinal Cord Injury Rehabilitation Association (Self) : Board Member/Advisory Panel (Status: Ongoing); CIHR (Self) : Operating Grant (Status: Ongoing), Other Financial or Material Support (Status: Ongoing), Research Support (Status: Ongoing); Coloplast (Self) : Other Financial or Material Support (Status: Ongoing), Unrestricted education funds (Status: Ongoing); Craig H Nielsen Foundation (Self) : Other Financial or Material Support (Status: Ongoing), Research Support (Status: Ongoing), Reviewer Stipend (Status: Ongoing); KITE Research Institute/University of Toronto (Self) : Other Financial or Material Support (Status: Ongoing), Research Support (Status: Ongoing), Sale and Distrbution of Knee positioners (Status: Ongoing); Ministry of Health Ontario (Self) : Research Support (Status: Ongoing); Praxis Spinal Research Institute (Self) : Board Member/Advisory Panel (Status: Ongoing), Consultant (Status: Ongoing), Research Support (Status: Ongoing); PVA (Self) : Other Financial or Material Support (Status: Terminated --- ), Travel Expenses (Status: Terminated --- )

    Jenny Kiratli, PhD (Moderator)

    Director of SCI Clinical Research

    Spinal Cord Injury & Disorders Center, VA Palo Alto Health Care System

    B. Jenny Kiratli, PhD, Director of Spinal Cord Injury Clinical Research, SCI/D Center, VA Palo ALto Health Care System. Dr Kiratli has over 35 years' experience conducting research on skeletal response to paralysis due to spinal cord injury. She received her PhD in 1989 from the University of Wisconsin-Madison; her dissertation was entitled "Skeletal adaptation to disuse: Longitudinal and cross-sectional study of the response of the femur and spine to immobilization (paralysis)." She had the opportunity to work with Dr Richard Mazess at Lunar Corp while conductng her PhD work and became an expert in DXA assessment in this unique population. In 1991, she was recruited to the VA Palo Alto Health Care System SCI Center where she developed a comprehensive research program encompassing musculoskeletal and cardiometabolic concerns for individuals living with SCI with an additional focus on activity and community recreation. Her current funding from VA Rehabilitation R&D supports a study entitled, "Assessing Bone Health after SCI: Establishing Evidence for a Clinical Protocol," that entails comparison of various DXA protocols for BMD of the proximal tiba and distal femur to establish precision in a non-injured reference cohort as well as those with SCI. Recently, she served on both groups working on clinical recommendations relevant to patients with SCI, the SCI Consortium Clinical Practice Guidelines for Bone Health after Spinal Cord Injury and the Orthopaedic Trauma Association Task Force on Fracture Management for SCI, both expected to be released in the Spring of 2022..

    Disclosures: No relationships to disclose.

    Course Planners and Managers

    Harold Rosen, MD, CCD No Financial Relationships to Disclose
    Wendy Tolman-Andrews, CBDT No Financial Relationships to Disclose
    Peter Brown, MS No Financial Relationships to Disclose
    Jesse Palmer No Financial Relationships to Disclose

    Course Content Reviewers

    William Leslie MD, FRCPC, MSc, CCD,  No Financial Relationships to Disclose

    Course Faculty, Moderators, and Content Authors

    Jenny Kiratli, Ph.D. No Financial Relationships to Disclose
    Anthony Scott Burns, MD, MSc, No Financial Relationships to Disclose
    Beverly Catherine Craven, Board Member/Advisory - Canadian Spinal Cord Injury Rehab Assoc; Praxis Spinal Research Institute Research Support - CIHR; Craigh H Nielsen Foundation; KITE Research Institute; Ministry of Health Ontario; Praxis Spinal Research Other - Coloplast; Craig H Nielsen Foundation; KITE Research Institute; PVA
    Christopher M Cirnigliaro, PhD., CBDT, No Financial Relationships to Disclose


    image

    Statement of Independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use 

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record learner’s personal information as provided on evaluations to allow for issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendee Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program. 

  • Topics to be covered include pre-screening, transferring onto and off of the scan table, positioning and scan acquisition, and analysis. The presentation will review the current state of the field regarding BMD of the knee as this is the most common fracture site for individuals with SCI and will reference the recent ISCD Position on BMD after SCI as well as two upcoming clinical practice guidelines for bone health and fracture management in this population.

    Activity approved for 1.0 ASRT Category A Credits
    Activity approved for up to 1.0 AMA PRA Category 1 Credits™
    Activity Expires December 1, 2023

    Activity Description

    Topics to be covered include pre-screening, transferring onto and off of the scan table, positioning and scan acquisition, and analysis. The presentation will review the current state of the field regarding BMD of the knee as this is the most common fracture site for individuals with SCI and will reference the recent ISCD Position on BMD after SCI as well as two upcoming clinical practice guidelines for bone health and fracture management in this population. 

    Learning Objectives

    1. Explain specific barriers and limitations related to performing DXA studies with individuals with SCI.
    2. Discuss considerations for acquiring BMD of the knee in individuals with SCI.
    3. Create a plan for conducting DXA studies with individuals with SCI.

    Instructions

    Clinicians and Technologists are required to answer a set of online test questions following the review of the video and will have up to three attempts to answer questions correctly before losing credit for the activity. Once the activity test has been passed (75% or higher), you will be asked to evaluate the activity online and then be allowed to claim credit and print certificates.

    Registration Fees

    image

    Cancellation Policy

    On-Demand/ Enduring Material Cancellation Purchases of on-demand or enduring educational materials are non-refundable. On-Demand/Enduring Material Program Changes or Cancellations  ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.

    ACCME Accreditation Statement

    The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.

    AMA PRA Category 1 Credit(s)™

    The International Society for Clinical Densitometry designates this enduring educational activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

    ASRT Credit Designation 

    This activity has been approved by ASRT for 1.00 Category A continuing education credits.

    Date of Original Release and most recent Review or Update 

    This activity was most recently reviewed and released on November 1, 2022, and will expire on December 1, 2023

    Jenny Kiratli, PhD

    Director of SCI Clinical Research

    Spinal Cord Injury & Disorders Center, VA Palo Alto Health Care System

    B. Jenny Kiratli, PhD, Director of Spinal Cord Injury Clinical Research, SCI/D Center, VA Palo ALto Health Care System. Dr Kiratli has over 35 years' experience conducting research on skeletal response to paralysis due to spinal cord injury. She received her PhD in 1989 from the University of Wisconsin-Madison; her dissertation was entitled "Skeletal adaptation to disuse: Longitudinal and cross-sectional study of the response of the femur and spine to immobilization (paralysis)." She had the opportunity to work with Dr Richard Mazess at Lunar Corp while conductng her PhD work and became an expert in DXA assessment in this unique population. In 1991, she was recruited to the VA Palo Alto Health Care System SCI Center where she developed a comprehensive research program encompassing musculoskeletal and cardiometabolic concerns for individuals living with SCI with an additional focus on activity and community recreation. Her current funding from VA Rehabilitation R&D supports a study entitled, "Assessing Bone Health after SCI: Establishing Evidence for a Clinical Protocol," that entails comparison of various DXA protocols for BMD of the proximal tiba and distal femur to establish precision in a non-injured reference cohort as well as those with SCI. Recently, she served on both groups working on clinical recommendations relevant to patients with SCI, the SCI Consortium Clinical Practice Guidelines for Bone Health after Spinal Cord Injury and the Orthopaedic Trauma Association Task Force on Fracture Management for SCI, both expected to be released in the Spring of 2022..

    Disclosures: No relationships to disclose.

    Christopher Cirnigliaro (Moderator)

    Investigator

    James J. Peters VA Medical Center

    Course Planners and Managers

    Harold Rosen, MD, CCD No Financial Relationships to Disclose
    Wendy Tolman-Andrews, CBDT No Financial Relationships to Disclose
    Peter Brown, MS No Financial Relationships to Disclose
    Jesse Palmer No Financial Relationships to Disclose

    Course Content Reviewers

    S. Kumar No Financial Relationships to Disclose

    Course Faculty, Moderators, and Content Authors

    Jenny Kiratli, Ph.D. No Financial Relationships to Disclose
    Christopher Cirnigliaro, Ph.D. No Financial Relationships to Disclose


    image

    Statement of Independence

    The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in course material. No Commercial Support has been provided for this activity

    Disclaimer

    The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

    Disclosure of Unlabeled Use 

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Privacy & Confidentiality Statement

    The ISCD will record learner’s personal information as provided on evaluations to allow for issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties

    Attendee Cancellation Policy

    All changes in registration must be made in writing to education@iscd.org. Purchase of on-demand or enduring educational materials are non-refundable.

    Course Changes or Cancellations

    ISCD reserves the right to cancel the program, change dates, and/or the location/method of offering. All program fees will be refunded if a program is canceled unless the registered participant elects to transfer to another program.